Cargando…
Real-world characteristics of T-cell apheresis and clinical response to tisagenlecleucel in B-cell lymphoma
Autores principales: | Cuffel, Alexis, Allain, Vincent, Faivre, Lionel, Di Blasi, Roberta, Morin, Florence, Vercellino, Laetitia, Chevalier, Mathieu F., Desnoyer, Aude, de Jorna, Romain, Madelaine, Isabelle, Parquet, Nathalie, Brignier, Anne C., Thieblemont, Catherine, Larghero, Jerome, Caillat-Zucman, Sophie, Mebarki, Miryam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636323/ https://www.ncbi.nlm.nih.gov/pubmed/35728051 http://dx.doi.org/10.1182/bloodadvances.2022007057 |
Ejemplares similares
-
Effect of early granulocyte-colony-stimulating factor administration in the prevention of febrile neutropenia and impact on toxicity and efficacy of anti-CD19 CAR-T in patients with relapsed/refractory B-cell lymphoma
por: Liévin, Raphaël, et al.
Publicado: (2022) -
A major role for CD4(+) T cells in driving cytokine release syndrome during CAR T cell therapy
por: Boulch, Morgane, et al.
Publicado: (2023) -
Human umbilical cord-derived mesenchymal stem/stromal cells: a promising candidate for the development of advanced therapy medicinal products
por: Mebarki, Miryam, et al.
Publicado: (2021) -
Positron emission tomography-imaging assessment for guiding strategy in patients with relapsed/refractory large B-cell lymphoma receiving CAR T cells
por: Galtier, Jean, et al.
Publicado: (2022) -
Tumor-intrinsic sensitivity to the pro-apoptotic effects of IFN-γ is a major determinant of CD4(+) CAR T-cell antitumor activity
por: Boulch, Morgane, et al.
Publicado: (2023)